Active surveillance prostate cancer test registry study
Part of Cancer clinical trials.
This study enrolls men with low-risk prostate cancer who are either staying on active surveillance or planning surgery soon. It uses a new “SNEP assay” test to help monitor prostate cancer over time and may improve how doctors track risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a man aged 40 to 80 years old
- Have a life expectancy of at least 10 years
- You must be either on active surveillance already or recently chose active surveillance vs surgery soon (see next questions)
- If you are on active surveillance: you must have only one prior low-grade biopsy and your first annual biopsy must be scheduled within 90 days
- If you are not on active surveillance: you must have recently been diagnosed with low-grade prostate cancer, decided against active surveillance, and have prostate surgery (radical prostatectomy) scheduled within 90 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows men with low-risk prostate cancer who choose active surveillance (watching closely instead of immediate treatment). It aims to better track which monitoring results stay reassuring over time, and when treatment might be needed.
This is a registry study that follows men with low-risk prostate cancer who choose active surveillance instead of immediate treatment. It helps doctors understand how safe and effective active surveillance is, including confirming results with repeat biopsies.
This trial studies a “watchful waiting” approach, where doctors closely monitor certain prostate cancers with regular checkups and repeat biopsies. It may help people avoid or delay treatment side effects while watching for signs the cancer needs treatment.
This study follows people with early-stage prostate cancer who choose active surveillance instead of immediate treatment. It aims to see how monitoring with repeat prostate biopsies and follow-up works over time.
This trial follows men with prostate cancer who choose “active surveillance” instead of immediate treatment. It tests whether careful tracking (including patient reports) can help manage cancer over time and guide decision-making.
This study checks whether people with a low chance of prostate cancer can be monitored closely without having an immediate prostate biopsy. It uses PSA blood tests and prostate MRI to sort who may safely wait.
Hear when a new Prostate Cancer Aggressiveness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.